Biotech

All Articles

Biogen, UCB record period 3 lupus succeed after neglecting earlier trial

.Biogen and UCB's gamble on improving right into period 3 astride a broken research study wants to h...

Aptadir really hopes brand new RNA inhibitors can easily turn around challenging cancers cells

.Italian biotech Aptadir Rehabs has actually launched along with the commitment that its own pipelin...

Wave surfs DMD results to regulatory authorities' doors, sending out stockpile

.Surge Life Sciences has fulfilled its own target in a Duchenne muscle dystrophy (DMD) research, pla...

Sanofi plucks new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is going back to the pharma crease, using up the...

Achilles drips tissue therapy plan, prepares for discharges after missing out on 'industrial practicality' objectives

.Achilles Therapeutics has actually wrecked its own technique. The British biotech is knocking off o...

Aligos heralds phase 2 MASH gain, reducing liver fat as much as 46%

.Aligos Rehabs is actually declaring a midstage gain in metabolic-dysfunction linked steatohepatitis...

Basilea credit ratings $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's work developing brand-new antifungals has obtained a considerable increase ...

Capricor markets Europe civil rights to late-stage DMD treatment for $35M

.Possessing presently gathered up the U.S. civil liberties to Capricor Therapies' late-stage Duchenn...

FDA junks adcomm for Applied's unusual health condition drug

.After pushing back the choice meeting for Applied Rehabs' metabolic disorder drug govorestat, the F...

Novo inks $600M NanoVation package to research hereditary drugs ex-liver

.Novo Nordisk is continuing its own push into hereditary medicines, consenting to pay NanoVation The...